China’s Can Sino Biologics is holding talks with Russia, Brazil, Chile and Saudi Arabia on starting phase III trials of COVID19 vaccine (AD5-NCOV), planning to enroll 40,000 participants. This came after the vaccine was approved for use in army. https://www.reuters.com/article/us-health-coronavirus-china-vaccine/chinas-cansino-in-talks-for-covid-vaccine-phase-iii-trial-overseas-idUSKCN24C0HS